Journal of Neurology

Article	Citations
Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset	160
Aseptic meningitis after glatiramer acetate	127
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up	113
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease	94
Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data	90
Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting	80
Cerebellar compensation: a case of aphasia due to cerebellar hemorrhage	75
Brain microstructure is linked to cognitive fatigue in early multiple sclerosis	73
[18F]DPA-714-PET-MRI reveals pronounced innate immunity in human anti-LGI1 and anti-CASPR2 limbic encephalitis	71
Advancing understanding and treatment of spinal muscular atrophy with four SMN2 copies: a critical review	70
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis	69
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	66
Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled tri	66
Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis	63
The rising role of cognitive reserve and associated compensatory brain networks in spinocerebellar ataxia type 2	63
Characterisation and differential diagnosis of neurological complications in adults with phenylketonuria: literature review and expert opinion	61
Exploring trajectory recovery curves of post-COVID cognitive symptoms in previously hospitalized COVID-19 survivors: the LONG-COVID-EXP-CM multicenter study	60
The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis	59
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study	56
Generalized epileptic discharges leading into focal onset seizure: GOFE seizures as the initial diagnosis of epilepsy	56
Feasibility and effects of cognitive training on cognition and psychosocial function in Huntington’s disease: a randomised pilot trial	55
Correction: Evolving management of Alzheimer’s disease	51
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	51
Discordant vestibulo-ocular reflex function according to the frequency and mode of stimulation	48
Contraversive saccadic hypermetria and ipsilateral limb ataxia: the brachium conjunctivum syndrome	47

Clinical and pathological aspects of toxic myopathies	46
Explaining recovery from coma with multimodal neuroimaging	45
Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis	45
Endovascular thrombectomy versus medical management for moderate-to-severe anterior cerebral artery occlusion stroke	45
Acute carotid stenting versus non-stenting treatment of acute ischemic stroke due to tandem lesions: a systematic review and meta-analysis	44
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells	41
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	40
Hereditary transthyretin amyloidosis: a myriad of factors that influence phenotypic variability	39
Hippocampal hub failure is linked to long-term memory impairment in anti-NMDA-receptor encephalitis: insights from structural connectome graph theoretical network analysis	39
Reduced 123I-MIBG uptake in the parotid and submandibular glands in patients with Parkinson’s disease identified using a quantitative semi-automatic method	39
Does repetitive transcranial magnetic stimulation have a beneficial effect on improving unilateral spatial neglect caused by stroke? A meta-analysis	38
Brain network topology and future development of freezing of gait in Parkinson’s disease: a longitudinal study	38
Clinical characteristics of overlapping syndrome in patients with GFAP-IgG and MOG-IgG: a case series of 8 patients and literature review	37
Evolution from viral encephalitis to autoimmune encephalitis to multiple sclerosis: a case report	37
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod	37
Henry J.M. Barnett (1922–2016)	36
Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy	36
Thalamic ventral-Oralis complex/rostral zona incerta deep brain stimulation for midline tremor	36
Automated algorithms for seizure forecast: a systematic review and meta-analysis	36
Richard Gundry Rows (1866–1925)	35
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	35
Rasmussen’s encephalitis: structural, functional, and clinical correlates of contralesional epileptiform activity	35
A multidimensional gender analysis of health technology self-efficacy among people with Parkinson’s disease	35
Impairment of oculomotor functions in patients with early to advanced amyotrophic lateral sclerosis	34
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience	33
Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort	33
Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectr	33
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series	33
Disability in cerebellar ataxia syndromes is linked to cortical degeneration	33
Neuropsychological and neuroimaging characteristics of classical superficial siderosis	33
John Langdon Haydon Down (1828–1896)	33
Acute serum free thiols: a potentially modifiable biomarker of oxidative stress following traumatic brain injury	32
Age-dependent perturbation of the perceptual and postural vertical by visual roll vection and susceptibility to motion sickness in children	32
Primary progressive aphasia: six questions in search of an answer	32
Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis	32
RNA interference in late-stage hereditary transthyretin amyloidosis: a clinicopathological study	31
Advances in the genetics of stroke risk and recovery	31
Initiation of antidepressants in young adults after ischemic stroke: a registry-based follow-up study	30
Acetyl-DL-leucine in combination with memantine improves acquired pendular nystagmus caused by multiple sclerosis: a case report	30
Radiation-induced intracranial vasculitis on high-resolution vessel wall MRI	29
Anticoagulation in intracranial haemorrhage with atrial fibrillation	29
Myasthenia gravis treatment in the elderly presents with a significant iatrogenic risk: a multicentric retrospective study	29
Safety and outcomes of endovascular treatment in patients with very severe acute ischemic stroke	29
Early intensive versus escalation treatment in patients with relapsing–remitting multiple sclerosis in Austria	28
Initial symptoms of vertebrobasilar artery occlusions and the outcomes after endovascular treatment	28
Herpetic encephalitis: which treatment for which body weight?	28
Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study	28
Effect of cerebral small vessel disease on the integrity of cholinergic system in mild cognitive impairment patients: a longitudinal study	28
Language impairment in the genetic forms of behavioural variant frontotemporal dementia	28
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution	27

Longitudinal predictors of health-related quality of life in isolated dystonia	27
New remote cerebral microbleeds in acute ischemic stroke: an analysis of the randomized, placebo-controlled WAKE-UP trial	27
Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?	27
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies	27
Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis	27
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience	27
Update on recent advances in amyotrophic lateral sclerosis	26
The various forms of hereditary motor neuron disorders and their historical descriptions	26
SARA captures disparate progression and responsiveness in spinocerebellar ataxias	26
Sequential alterations in diffusion metrics as correlates of disease severity in amyotrophic lateral sclerosis	26
Sidney Ochs (1924–2014)	25
Short term cardiovascular symptoms improvement after deep brain stimulation in patients with Parkinson's disease: a systematic review	25
Rafael Lorente de Nó (1902–1990)	25
Diverse faces of GNAO1: mild forms in epilepsy and autism	25
The grasp reflex in patients with idiopathic normal pressure hydrocephalus	25
Varicella zoster vasculopathy associated with deep intracerebral haemorrhage	24
Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab	24
Psychological impact of COVID-19 containment on CADASIL patients	24
Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experiment	24
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study	24
Relationships between intracranial arterial dolichoectasia and small vessel disease in patients with ischaemic stroke: a systematic review and meta-analysis	23
Managing blood pressure in acute cerebral infarction	23
Neurological update: the palliative care landscape for atypical parkinsonian syndromes	23
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung	23
Short-read genome sequencing allows ‘en route’ diagnosis of patients with atypical Friedreich ataxia	23
Structural MRI substrate of long-duration response to levodopa in Parkinson’s disease: an exploratory study	23
Supporting brain health in multiple sclerosis: exploring the potential of neuroeducation combined with practical mindfulness exercises in the management of neuropsychological symptoms	23
Punctuate hippocampal lesions presenting with acute vestibular syndrome	23
Additive effect of DNAJC30 and NDUFA9 mutations causing Leigh syndrome	23
Progression to corticobasal syndrome: a longitudinal study of patients with nonfluent primary progressive aphasia and primary progressive apraxia of speech	23
Acute pediatric encephalitis: etiology, course, and outcome of a 12-year single-center immunocompetent cohort	23
The influence of depression and anxiety on cognition in people with multiple sclerosis: a cross-sectional analysis	22
The socioeconomic burden of facioscapulohumeral muscular dystrophy	22
Multiverse to inform neurological research: an example using recovery outcome of neglect	22
Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study	22
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a	22
The DeMyers: Marian (1922–2012) and William (1924–2008)	22
Determinant of the cerebellar cognitive affective syndrome in Friedreich’s ataxia	22
Coping strategies among amyotrophic lateral sclerosis (ALS) patients: an integrative review	22
CIDP-like autoimmune nodopathy complicated with focal segmental glomerulosclerosis: a case study and literature review	21
Does visuospatial motion perception correlate with coexisting movement disorders in Parkinson’s disease?	21
Spontaneous intracranial hypotension: features, diagnosis and management	21
Clinical trials for cerebellar ataxia	21
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	21
Pooled analysis of patients with inherited prion disease caused by two- to twelve-octapeptide repeat insertions in the prion protein gene (PRNP)	21
Acute corticospinal tract diffusion tensor imaging predicts 6-month functional outcome after intracerebral haemorrhage	21
Real-world experience with VMAT2 inhibitors in Tourette syndrome	21
Adult occipital lobe epilepsy: 12-years on	21
Richard Stern (1878–1942)	21
Amyotrophic lateral sclerosis: an update on treatments from clinical trials	21
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	21
Neuroimaging uncovers distinct relationships of glymphatic dysfunction and motor symptoms in Parkinson’s disease	21
Neurological manifestation of HEV infection: still a rare disease entity?	21
Investigating the relationship between mild traumatic brain injury and Alzheimer’s disease and related dementias: a systematic review	21
Concurrence of seizures and peri-ictal delirium in the critically ill - its frequency, associated characteristics, and outcomes	21
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	21
Generalization of ocular myasthenia gravis 10 years after onset	21
Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results	20
Description of the first Spanish case of Gerstmann–Sträussler–Scheinker disease with A117V variant: clinical, histopathological and biochemical characterization	20
Plasma neurofilament light as a promising biomarker in neuronal intranuclear inclusion disease	20
Clinical features and recovery pattern of secondary hypokalaemic paralysis	20
Microembolic signals and antiplatelet therapy in Moyamoya angiopathy	20
In memoriam: Prof. Dr. John H. J. Wokke (1952–2022)	20
Elderly onset neuromyelitis optica spectrum disorder: a case report	20
Multisensory hallucinations and other unusual sensory experiences in the context of migraine: a systematic review	20
Status dystonicus in adult patients with anti-N-methyl-d-aspartate-acid receptor encephalitis	19
Repeated erythema and pain in the lateral thoracic region due to spinal cord infarction: a case report	19
Functional movement disorders triggered by reality shifting and the Backrooms—another social media traps	19
Natalizumab-induced pneumonitis	19
Cerebellopontine angle tumor presenting as vertical strabismus: differentiation of trochlear nerve palsy and skew deviation	19
Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis	19
Autonomic dysfunction in long-COVID syndrome: a neurophysiological and neurosonology study	19
Progression rate of radiation-induced carotid stenosis in head and neck cancer survivors after statin treatment: a retrospective cohort study	18
Heterogeneity of persisting symptoms after sport-related concussion (SRC): exploring symptom subtypes and patient subgroups	18
Patient acceptance of teleneurology across neurologic conditions	18
Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an expert opinion and practical guideline	18
Risk of mortality from suicide in patients with Huntington’s disease is increased compared to the general population in England	18
Correlation between clinical severity and extent of autonomic cardiovascular impairment in the acute phase of subarachnoid hemorrhage	18
SARS-CoV-2 in patients with Friedreich ataxia	18
Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease	18

Brain structural abnormalities in the preclinical stage of Machado–Joseph disease/spinocerebellar ataxia type 3 (MJD/SCA3): evaluation by MRI morphometry, diffusion tensor imaging and neurite orientat	18
Reduced eye gaze fixation during emotion recognition among patients with temporal lobe epilepsy	18
Direction and magnitude of displacement differ between slowly expanding and non-expanding multiple sclerosis lesions as compared to small vessel disease	18
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease	18
DNA hypermethylation of NOTCH2NLC in neuronal intranuclear inclusion disease: a case–control study	18
The trigeminal pathways	18
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	18
Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound	18
Premorbid frailty predicts short- and long-term outcomes of reperfusion treatment in acute stroke	18
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	18
A role for the Epstein–Barr virus in multiple sclerosis aetiology?	17
Adaptive deep brain stimulation for Parkinson’s disease: looking back at the past decade on motor outcomes	17
Anti-titin antibodies are associated with myocarditis in patients with myasthenia gravis	17
The resilience of the inner ear—vestibular and audiometric impact of transmastoid semicircular canal plugging	17
Complications of reversible cerebral vasoconstriction syndrome in relation to age	17
Takotsubo cardiomyopathy in Guillain–Barré syndrome	17
Clinical characteristics and treatment approaches in patients with Susac syndrome: a scoping review of cases	17
Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?	17
Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error rates	17
Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP)	17
CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma	17
Identifying the mediating role of inflammation on the relationship between socioeconomic status and Alzheimer’s disease: a Mendelian randomization analysis and mediation analysis	17
Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers	17
Cognitive impairment in psoriasis patients: a systematic review of case–control studies	17
Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies	17
A whole new world: embracing the systems-level to understand the indirect impact of pathology in neurodegenerative disorders	17
Common neural correlates of vestibular stimulation and fear learning: an fMRI meta-analysis	17
DCTN1 mutation associated parkinsonism: case series of three new families with perry syndrome	17
Two-year longitudinal follow-up of visual illusions and hallucinations in Parkinson’s disease	17
Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02)	17
Alemtuzumab induces severe orbitopathy in relapsing–remitting multiple sclerosis	17
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease	17
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment	17
Does radiological conjugate eye deviation sign play a role in acute stroke imaging? A meta-analysis	16
Incidence and risk factors of epilepsy following brain arteriovenous malformation rupture in adult patients	16
Recent advances in novel mutation genes of Parkinson's disease	16
Diana Jean Kinloch Beck (1902–1956)	16
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	16
The diagnostic value of the neurological examination in coma of unknown etiology	16
Long-term outcome after decompressive hemicraniectomy for malignant middle cerebral artery infarction	16
Endovascular treatment of ischemic stroke due to isolated internal carotid artery occlusion: ETIS registry data analysis	16
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update	16
An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy	16
Clinical features and maternal and fetal outcomes in women with Guillain-Barré syndrome in pregnancy	16
Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?	16
Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report	16
Neuroimmune disorders in COVID-19	16
Neural correlates of dual-task walking in people with central neurological disorders: a systematic review	16
Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial	16
Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications	16
Late-onset MS is associated with an increased rate of reaching disability milestones	15
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis	15
Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death	15
Risk and cause of death in post-traumatic epilepsy: a register-based retrospective cohort study	15
Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study	15
Acute recanalization therapy for ischemic stroke during pregnancy and puerperium	15
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?	15
Covid-19 and Parkinson’s disease: an overview	15
Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer’s disease by integrated bioinformatics	15
Blood pressure variability predicts poor outcomes in acute stroke patients without thrombolysis: a systematic review and meta-analysis	15
Functional connectivity modifications in monoaminergic circuits occur in fatigued MS patients treated with fampridine and amantadine	15
Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome	15
Evolution of caloric responses during and between the attacks of Meniere’s disease	15
Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson’s disease patients	15
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocyto	15
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	15
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study	15
Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping	15
Imaging-based outcome prediction in posterior circulation stroke	15
In vivo characterization of microglia and myelin relation in multiple sclerosis by combined 11C-PBR28 PET and synthetic MRI	15
Sleep disturbances associated with DPPX autoantibodies: a case series	15
The phenotypic spectrum of KCNT1: a new family with variable epilepsy syndromes including mild focal epilepsy	15
Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis	15
Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis	15
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod	15
Unveiling the invisible: a qualitative interview study on the impact of young onset Parkinson’s disease on (ex-)partners	15
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	15
The natural history of primary progressive aphasia: beyond aphasia	15
Increased aneurysm wall permeability colocalized with low wall shear stress in unruptured saccular intracranial aneurysm	15
Dystonia management across Europe within ERN-RND: current state and future challenges	14
Novel ultrasound neuromodulation therapy with transcranial pulse stimulation (TPS) in Parkinson’s disease: a first retrospective analysis	14
Periorbital injections of botulinum toxin a: a novel therapeutic option for convergence spasm in neuropsychiatric disorders	14
Cerebellar ataxia and myeloradiculopathy associated with AP3B2 antibody: a case report and literature review	14
What happens after fingolimod discontinuation? A multicentre real-life experience	14
Clinical spreading of muscle weakness in amyotrophic lateral sclerosis (ALS): a study in 910 patients	14
Glymphatic function from diffusion-tensor MRI to predict conversion from mild cognitive impairment to dementia in Parkinson’s disease	14
Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis	14
Hippocampal sclerosis is associated with celiac disease type immunity in patients with drug-resistant temporal lobe epilepsy	14
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis	14
Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy	14
An MRI evaluation of white matter involvement in paradigmatic forms of spastic ataxia: results from the multi-center PROSPAX study	14
Transcranial direct current stimulation in neglect rehabilitation after stroke: a systematic review	14
Non-invasive perfusion territory quantification and time-resolved angiography by arterial spin labeling in a patient with a large right-hemispheric AVM: case report	14
Brainstem–cortex disconnection in amyotrophic lateral sclerosis: bulbar impairment, genotype associations, asymptomatic changes and biomarker opportunities	14
Recent applications of quantitative electroencephalography in adult intensive care units: a comprehensive review	14